AUB ScholarWorks

Duration of post-surgical antibiotics in chronic osteomyelitis: Empiric or evidence-based?

Show simple item record

dc.contributor.author Haidar R.
dc.contributor.author Boghossian A.D.
dc.contributor.author Atiyeh B.
dc.contributor.editor
dc.date Sep-2010
dc.date.accessioned 2017-10-05T16:07:33Z
dc.date.available 2017-10-05T16:07:33Z
dc.date.issued 2010
dc.identifier 10.1016/j.ijid.2010.01.005
dc.identifier.isbn
dc.identifier.issn 12019712
dc.identifier.uri http://hdl.handle.net/10938/19878
dc.description.abstract Chronic osteomyelitis is a relatively common infection and is often a lifelong disease. Traditionally, osteomyelitis has been treated with 4-6 weeks of parenteral antibiotics after definitive debridement surgery. Antibiotic-impregnated cement beads have also been used as adjuvant therapy for chronic osteomyelitis. However, this time frame of antibiotic treatment has no documented superiority over other time intervals, and there is no evidence that prolonged parenteral antibiotics will penetrate the necrotic bone. There is no solid evidence in the medical literature to support the continuous use of long duration antibiotic treatment for chronic osteomyelitis. A small number of comparative trials on the treatment of chronic osteomyelitis have been published. Also, the type of surgical procedures practiced in the past in treating chronic osteomyelitis and the lack of effective muscle flap application might have contributed to the prolonged antibiotic treatment. And although the surgical approach to the treatment of chronic osteomyelitis has advanced markedly, still the same duration of antibiotic treatment is adopted. In this review we question the continuous and traditional use of long-term antibiotic treatment for chronic osteomyelitis in spite of the advances in surgical treatment using flaps. The medical literature, including studies in animals and humans, was searched for evidence to support the use of short courses of antibiotics. We hope this review will provoke the initiation of animal studies and clinical trials assessing the use of short courses of antibiotics for chronic osteomyelitis. © 2010 International Society for Infectious Diseases.
dc.format.extent
dc.language English
dc.publisher OXFORD
dc.relation.ispartof Publication Name: International Journal of Infectious Diseases; Publication Year: 2010; Volume: 14; no. 9;
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Duration of post-surgical antibiotics in chronic osteomyelitis: Empiric or evidence-based?
dc.type Review
dc.contributor.affiliation Haidar, R., Department of Surgery, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon
dc.contributor.affiliation Boghossian, A.D., Department of Surgery, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon
dc.contributor.affiliation Atiyeh, B., Department of Surgery, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon
dc.contributor.authorAddress Haidar, R.; Department of Surgery, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon; email: rh00@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Surgery;
dc.contributor.authorDepartment Surgery
dc.contributor.authorDivision
dc.contributor.authorEmail rh00@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Haidar, R
dc.contributor.authorInitials Boghossian, AD
dc.contributor.authorInitials Atiyeh, B
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Haidar, R (reprint author), Amer Univ Beirut, Med Ctr, Dept Surg, POB 11-0236, Beirut 11072020, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Akinyoola AL, 2009, ARCH ORTHOP TRAUM SU, V129, P449, DOI 10.1007-s00402-008-0621-y; ANTHONY JP, 1991, PLAST RECONSTR SURG, V88, P311, DOI 10.1097-00006534-199108000-00023; BUCHHOLZ HW, 1970, CHIRURG, V41, P511; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; DART AJ, 1996, AUST VET J, V13, P73; EDMONDSO.HT, 1973, ANN SURG, V178, P637, DOI 10.1097-00000658-197311000-00014; EVANS RP, 1993, CLIN ORTHOP RELAT R, P37; FASS RJ, 1978, ANTIMICROB AGENTS CH, V13, P405; Finney MS, 2005, CURR MED RES OPIN, V21, P1923, DOI 10.1185-030079905X74961; Galanakis N, 1997, J ANTIMICROB CHEMOTH, V39, P241, DOI 10.1093-jac-39.2.241; GEDDES AM, 1964, BRIT MED J, V2, P670; GENTRY LO, 1990, ANTIMICROB AGENTS CH, V34, P40; GREEN SA, 1984, J BONE JOINT SURG AM, V66A, P1092; GREENBERG RN, 1990, ANTIMICROB AGENTS CH, V34, P2392; GRONDIN C, 1965, CAN MED ASSOC J, V92, P1062; Guelinckx PJ, 1995, MICROSURG, V16, P606, DOI 10.1002-micr.1920160906; Henry S L, 1991, Orthop Rev, V20, P242; Herzog L, 2002, J Orthop Surg (Hong Kong), V10, P114; Kadry AA, 2004, J ANTIMICROB CHEMOTH, V54, P1103, DOI 10.1093-jac-dkh465; Kinik H, 2008, INT ORTHOP, V32, P551, DOI 10.1007-s00264-007-0342-9; KLEMM K, 1979, ZBL CHIR, V104, P934; KLEMM KW, 1993, CLIN ORTHOP RELAT R, P63; KNOPP W, 1987, Handchirurgie Mikrochirurgie Plastische Chirurgie, V19, P98; KORKUSUZ F, 1993, J BONE JOINT SURG BR, V75, P111; LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002-jor.1100110213; Lazzarini L, 2005, INT J INFECT DIS, V9, P127, DOI 10.1016-j.ijid.2004.09.009; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305; Lew DP, 2004, LANCET, V364, P369; LOFFLER L, 1986, REV INFECT DIS, V8, pS593; Mader JT, 1999, CLIN ORTHOP RELAT R, P47; MADER JT, 1983, J BONE JOINT SURG AM, V65, P507; MADER JT, 1993, CLIN ORTHOP RELAT R, P87; MAJID SA, 1985, ACTA ORTHOP SCAND, V56, P265; MATHES SJ, 1982, PLAST RECONSTR SURG, V69, P815, DOI 10.1097-00006534-198205000-00018; MCCLOSKEY RV, 1977, ANTIMICROB AGENTS CH, V12, P636; MEIBNER A, 1989, INFECTION, V17, P146; Monzon M, 2001, J ORTHOPAED RES, V19, P820, DOI 10.1016-S0736-0266(00)00076-0; NELSON DR, 1990, INFECTION, V18, P246, DOI 10.1007-BF01643399; NETTLES JL, 1969, J BONE JOINT SURG AM, VA 51, P230; NORDEN CW, 1983, REV INFECT DIS, V5, pS491; NORDEN CW, 1988, REV INFECT DIS, V10, P103; NORDEN CW, 1980, ANTIMICROB AGENTS CH, V17, P591; NORDEN CW, 1982, ANTIMICROB AGENTS CH, V21, P62; Park G, 2010, J PLAST RECONSTR AES, V63, P153, DOI 10.1016-j.bjps.2008.07.018; Parsons Brad, 2004, Am J Surg, V188, P57, DOI 10.1016-S0002-9610(03)00292-7; POTTAGE JC, 1984, REV INFECT DIS, V6, pS728; Ramos OM, 2002, PEDIATR INFECT DIS J, V21, P431, DOI 10.1097-01.inf.0000014472.98790.75; REINHARDT JF, 1986, REV INFECT DIS, V8, pS569; RICHARDS RR, 1991, J BONE JOINT SURG AM, V73A, P1323; RISSING JP, 1985, INFECT IMMUN, V47, P581; ROMEROVIVAS J, 1985, ANTIMICROB AGENTS CH, V28, P222; Rubino C, 2009, J PLAST RECONSTR AES, V62, pE401, DOI 10.1016-j.bjps.2007.12.053; Salgado CJ, 2006, PLAST RECONSTR SURG, V118, P1401, DOI 10.1097-01.prs.0000239579.37760.92; SCHURMAN DJ, 1979, REV INFECT DIS, V1, P206; Seligson D, 1984, J Ky Med Assoc, V82, P25; SHCHERBIN F G, 1990, Antibiotiki i Khimioterapiya, V35, P40; Shirtliff ME, 2001, J ANTIMICROB CHEMOTH, V48, P253, DOI 10.1093-jac-48.2.253; Shuford JA, 2003, CURR OPIN INFECT DIS, V16, P515, DOI 10.1097-01.qco.0000104289.87920.77; Sia IG, 2006, BEST PRACT RES CL RH, V20, P1065, DOI 10.1016-j.berh.2006.08.014; Simpson AHRW, 2001, J BONE JOINT SURG BR, V83B, P403, DOI 10.1302-0301-620X.83B3.10727; Solberg BD, 1999, J ORTHOP TRAUMA, V13, P102, DOI 10.1097-00005131-199902000-00006; Stengel D, 2001, Lancet Infect Dis, V1, P175, DOI 10.1016-S1473-3099(01)00094-9; TAYLOR B, 2003, BRIT MED J, V11, P322; Tetsworth K, 1999, CLIN ORTHOP RELAT R, P87; WALENKAMP GHIM, 1986, CLIN ORTHOP RELAT R, P171; Wang J, 2002, ORTHOPEDICS, V25, P1247; Yin LY, 2005, J ANTIMICROB CHEMOTH, V55, P995, DOI 10.1093-jac-dki109; Zuluaga AF, 2002, BMC INFECT DIS, V2, DOI 10.1186-1471-2334-2-8
dc.description.citedCount 17
dc.description.citedTotWOSCount 12
dc.description.citedWOSCount 8
dc.format.extentCount
dc.identifier.articleNo
dc.identifier.coden IJIDF
dc.identifier.pubmedID 20471296
dc.identifier.scopusID 77956617062
dc.identifier.url
dc.publisher.address THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Int. J. Infect. Dis.
dc.relation.ispartOfIssue 9
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle International Journal of Infectious Diseases
dc.relation.ispartofPubTitleAbbr Int. J. Infect. Dis.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 14
dc.source.ID WOS:000282101100004
dc.type.publication Journal
dc.subject.otherAuthKeyword Antibiotic treatment
dc.subject.otherAuthKeyword Chronic osteomyelitis
dc.subject.otherAuthKeyword Debridement
dc.subject.otherAuthKeyword Empiric
dc.subject.otherAuthKeyword Muscle flaps
dc.subject.otherAuthKeyword Review
dc.subject.otherChemCAS ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0
dc.subject.otherChemCAS aztreonam, 78110-38-0
dc.subject.otherChemCAS cefalexin, 15686-71-2, 23325-78-2
dc.subject.otherChemCAS cefalotin, 153-61-7, 58-71-9
dc.subject.otherChemCAS cefazolin, 25953-19-9, 27164-46-1
dc.subject.otherChemCAS cefotaxime, 63527-52-6, 64485-93-4
dc.subject.otherChemCAS cefoxitin, 33564-30-6, 35607-66-0
dc.subject.otherChemCAS cefsulodin, 52152-93-9
dc.subject.otherChemCAS cephalosporin, 11111-12-9
dc.subject.otherChemCAS ciprofloxacin, 85721-33-1
dc.subject.otherChemCAS clindamycin, 18323-44-9
dc.subject.otherChemCAS cloxacillin, 61-72-3, 642-78-4
dc.subject.otherChemCAS daptomycin, 103060-53-3
dc.subject.otherChemCAS fosfomycin, 23155-02-4
dc.subject.otherChemCAS gentamicin, 1392-48-9, 1403-66-3, 1405-41-0
dc.subject.otherChemCAS lincomycin, 154-21-2, 7179-49-9, 859-18-7
dc.subject.otherChemCAS meropenem, 96036-03-2
dc.subject.otherChemCAS ofloxacin, 82419-36-1
dc.subject.otherChemCAS pefloxacin, 70458-92-3
dc.subject.otherChemCAS penicillin G, 1406-05-9, 61-33-6
dc.subject.otherChemCAS sulbactam, 68373-14-8
dc.subject.otherChemCAS teicoplanin, 61036-62-2, 61036-64-4
dc.subject.otherChemCAS tetracycline, 23843-90-5, 60-54-8, 64-75-5, 8021-86-1
dc.subject.otherChemCAS Anti-Bacterial Agents
dc.subject.otherIndex ampicillin
dc.subject.otherIndex antibiotic agent
dc.subject.otherIndex aztreonam
dc.subject.otherIndex bone cement
dc.subject.otherIndex cefalexin
dc.subject.otherIndex cefalotin
dc.subject.otherIndex cefazolin
dc.subject.otherIndex cefotaxime
dc.subject.otherIndex cefoxitin
dc.subject.otherIndex cefsulodin
dc.subject.otherIndex cephalosporin
dc.subject.otherIndex ciprofloxacin
dc.subject.otherIndex clindamycin
dc.subject.otherIndex cloxacillin
dc.subject.otherIndex daptomycin
dc.subject.otherIndex fosfomycin
dc.subject.otherIndex gentamicin
dc.subject.otherIndex gentamicin bone cement
dc.subject.otherIndex lincomycin
dc.subject.otherIndex meropenem
dc.subject.otherIndex ofloxacin
dc.subject.otherIndex pefloxacin
dc.subject.otherIndex penicillin G
dc.subject.otherIndex sulbactam
dc.subject.otherIndex teicoplanin
dc.subject.otherIndex tetracycline
dc.subject.otherIndex antibiotic therapy
dc.subject.otherIndex chronic drug administration
dc.subject.otherIndex chronic osteomyelitis
dc.subject.otherIndex chronotherapy
dc.subject.otherIndex clinical effectiveness
dc.subject.otherIndex clinical trial
dc.subject.otherIndex debridement
dc.subject.otherIndex drug delivery system
dc.subject.otherIndex drug efficacy
dc.subject.otherIndex empiricism
dc.subject.otherIndex evidence based practice
dc.subject.otherIndex human
dc.subject.otherIndex nonhuman
dc.subject.otherIndex postoperative period
dc.subject.otherIndex review
dc.subject.otherIndex surgical approach
dc.subject.otherIndex tissue graft
dc.subject.otherIndex treatment duration
dc.subject.otherIndex Animals
dc.subject.otherIndex Anti-Bacterial Agents
dc.subject.otherIndex Chronic Disease
dc.subject.otherIndex Debridement
dc.subject.otherIndex Drug Administration Schedule
dc.subject.otherIndex Empirical Research
dc.subject.otherIndex Evidence-Based Practice
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Osteomyelitis
dc.subject.otherIndex Rabbits
dc.subject.otherIndex Rats
dc.subject.otherIndex Surgical Flaps
dc.subject.otherKeywordPlus STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS
dc.subject.otherKeywordPlus GENTAMICIN-PMMA-BEADS
dc.subject.otherKeywordPlus MUSCLE FLAP
dc.subject.otherKeywordPlus ANTIMICROBIAL TREATMENT
dc.subject.otherKeywordPlus PSEUDOMONAS-AERUGINOSA
dc.subject.otherKeywordPlus BACTERIAL-INFECTIONS
dc.subject.otherKeywordPlus JOINT INFECTIONS
dc.subject.otherKeywordPlus SOFT-TISSUE
dc.subject.otherKeywordPlus RAT MODEL
dc.subject.otherKeywordPlus BONE
dc.subject.otherWOS Infectious Diseases


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account